Versanis Bio snags $70M for a ditched Novartis muscle drug, with a little help from its old CEO Jimenez | Fierce Biotech

Generating your feed, please be patient ...

Versanis Bio snags $70M for a ditched Novartis muscle drug, with a little help from its old CEO Jimenez | Fierce Biotech | Zootzle